-
with an international reputation for excellence. The Department has a substantial research programme, with major funding from Medical Research Council (MRC), Wellcome Trust and National Institute
-
with an international reputation for excellence. The Department has a substantial research programme, with major funding from Medical Research Council (MRC), Wellcome Trust and National Institute
-
, an ambitious research programme investigating how genomic differences between individuals drive behavioural diversity and innovation across animals and humans. You will play a central role in supporting
-
in the job description (appendix 1). The RAI is Oxford’s centre for the study of the United States and its place in the world. Every year we host a full programme of research seminars and events which
-
About the role We are seeking a full-time Postdoctoral Research Assistant or Research Assistant with relevant experience to join the Control group at the Department of Engineering Science in central Oxford. The post is funded by The Faraday Institution and is fixed term to 30 September...
-
We invite applications for a Research Software Engineer to join the Oxford Protein Informatics Group (OPIG). This exciting position is unique within the University and will provide an unrivalled and
-
The Oxford Applied and Theoretical Machine Learning group at the Department of Computer Science has a new opening for a Project Support Officer, working together with Professor Yarin Gal. In
-
the College’s research programme, as well as being able to teach high-achieving graduate students. Additionally, they will possess excellent oral and written communication and interpersonal skills and
-
Senior Quality Assurance (QA) Analyst, IT Services Are you a highly skilled Senior Analyst, passionate about software quality, innovation, and continuous improvement? Join our dynamic IT Services team at the University of Oxford and help shape the future of product testing across our...
-
Medicine, University of Oxford is to re-programme immune cells as part of a larger programme to develop novel therapeutics (viral vector and/or extracellular vesicle-based) for myocardial regeneration. Key